Xavier Cos

ORCID: 0000-0003-3943-479X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Treatment and Management
  • Diabetes Management and Education
  • Diabetes Management and Research
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Chronic Disease Management Strategies
  • Metabolism, Diabetes, and Cancer
  • Clinical practice guidelines implementation
  • Diabetes and associated disorders
  • COVID-19 and healthcare impacts
  • Obesity and Health Practices
  • Pharmacology and Obesity Treatment
  • Chronic Kidney Disease and Diabetes
  • COVID-19 Clinical Research Studies
  • Health and Lifestyle Studies
  • Medication Adherence and Compliance
  • Health Systems, Economic Evaluations, Quality of Life
  • Wound Healing and Treatments
  • Diabetic Foot Ulcer Assessment and Management
  • Pancreatic function and diabetes
  • Health Promotion and Cardiovascular Prevention
  • Pressure Ulcer Prevention and Management
  • Diet and metabolism studies
  • Blood Pressure and Hypertension Studies
  • Primary Care and Health Outcomes
  • Potassium and Related Disorders

Institut Universitari d'Investigació en Atenció Primària Jordi Gol
2015-2024

Institut Català de la Salut
2014-2024

Instituto de Salud Carlos III
2023-2024

Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
2023-2024

University of Leicester
2019-2022

Universitat Autònoma de Barcelona
2010-2022

Consorci d’Atenció Primària de Salut Barcelona Esquerra
2022

Government of Catalonia
2014-2022

Stavros Niarchos Foundation
2022

Public Health Laboratory Ivo de Carneri
2021

Bernhard Paulweber Paul Valensi Jaana Lindström Nebojša Lalić Colin Greaves and 95 more Martin McKee Katarzyna Kissimova‐Skarbek Stavros Liatis E. Cosson Julia Szendroedi K. Sheppard Kate Charlesworth A. Felton Michael Hall Annu-Riikka Susanna Rissanen Jaakko Tuomilehto Peter E. H. Schwarz Michael Roden M. Paulweber Andreas Stadlmayr Lyudmyla Kedenko Nikolaos Katsilambros Konstantinos Makrilakis Zdravko Kamenov Philip Evans Aleksandra Gilis‐Januszewska Katarina Lalić Aleksandra Jotić P. Djordevic Vesna Dimitrijević-Srećković U. Hühmer Bernhard Kulzer Sabine Puhl Y. Lee-Barkey Ala’a Alkerwi Charles Abraham Wendy Hardeman Tania Acosta M. Adler Ala’a Alkerwi Noël C. Barengo R Barengo José Manuel Boavida Kate Charlesworth V. Christov B Claussen Xavier Cos E. Cosson S. Deceukelier Vesna Dimitrijević-Srećković Predrag Djordjević Philip Evans A. Felton María Isabel Fischer Rafael Gabriel-Sánchez Aleksandra Gilis‐Januszewska Margalit Goldfracht Joseph E. Gomez Colin Greaves Michael Hall Ulrich Handke Hans Hauner Jeffrey H. Herbst Norbert Hermanns L. Herrebrugh Claudia Huber U. Hühmer Jussi K. Huttunen Aleksandra Jotić Zdravko Kamenov S. Karadeniz Nikolaos Katsilambros Mykola Khalangot Katarzyna Kissimova‐Skarbek D Köhler Vincent J. Kopp Peter Kronsbein Bernhard Kulzer D. Kyne‐Grzebalski Katarina Lalić Nebojša Lalić R. Landgraf Y. Lee-Barkey Stavros Liatis Jaana Lindström Konstantinos Makrilakis Cameron N. McIntosh Martin McKee Ana Cristina Mesquita D. Misina F. Muylle Anne Neumann Anabela Paiva Pia Pajunen Bernhard Paulweber Markku Peltonen Luz Perrenoud A. Pfeiffer Auli Pölönen Sabine Puhl

The prevalence and socioeconomic burden of type 2 diabetes (T2DM) associated co-morbidities are rising worldwide.This guideline provides evidence-based recommendations for preventing T2DM.A European multidisciplinary consortium systematically reviewed the evidence on effectiveness screening interventions T2DM prevention using SIGN criteria.Obesity sedentary lifestyle main modifiable risk factors. Age ethnicity non-modifiable Case-finding should follow a step-wise procedure questionnaires...

10.1055/s-0029-1240928 article EN Hormone and Metabolic Research 2010-04-01
Jaana Lindström Anne Neumann K. Sheppard Aleksandra Gilis‐Januszewska Colin Greaves and 95 more Ulrich Handke Pia Pajunen Sabine Puhl Auli Pölönen A Rissanen Michael Roden T. Stemper V. Telle-Hjellset Jaakko Tuomilehto Džilda Veličkienė P. Schwarz Tania Acosta M. Adler Ala’a Alkerwi Noël C. Barengo R Barengo José Manuel Boavida Kate Charlesworth V. Christov B Claussen Xavier Cos E. Cosson S. Deceukelier Vesna Dimitrijević-Srećković Predrag Djordjević Philip Evans A.-M. Felton María Isabel Fischer Rafael Gabriel-Sánchez Aleksandra Gilis‐Januszewska Margalit Goldfracht J Gómez Colin Greaves Michael Hall Ulrich Handke Hans Hauner Jeffrey H. Herbst Norbert Hermanns L. Herrebrugh Claudia Huber U. Hühmer Jussi K. Huttunen Aleksandra Jotić Zdravko Kamenov S. Karadeniz Nikolaos Katsilambros Mykola Khalangot Katarzyna Kissimova‐Skarbek D Köhler Vincent J. Kopp Peter Kronsbein Bernhard Kulzer D. Kyne‐Grzebalski Katarina Lalić Nebojša Lalić R. Landgraf Y. Lee-Barkey Stavros Liatis Jaana Lindström Konstantinos Makrilakis C. McIntosh Martin McKee Ana Cristina Mesquita D. Misina F. Muylle Anne Neumann Anabela Paiva Pia Pajunen Bernhard Paulweber Markku Peltonen Luz Perrenoud A. Pfeiffer Auli Pölönen Sabine Puhl Falcão Raposo T. Reinehr A Rissanen Chris Robinson Michael Roden Ulrike Rothe Timo Saaristo Jamie L. Scholl P. Schwarz K. Sheppard S. Spiers T. Stemper Bernd Stratmann J Szendroedi Z Szybiński Tsvetalina Tankova V. Telle-Hjellset G. Terry Daniel Tolks F. Toti Jaakko Tuomilehto

When we ask people what they value most, health is usually top of the list. While effective care available for many chronic diseases, fact remains that patient, tax payer and whole society: Prevention Better Than Cure.

10.1055/s-0029-1240975 article EN Hormone and Metabolic Research 2010-04-01

AimsClinical inertia, the tendency to maintain current treatment strategies despite results demanding escalation, is thought substantially contribute disconnect between clinical aspirations for patients with diabetes and targets achieved. We wished explore potential causes of inertia among physicians people diabetes.MethodsA 20-min online survey 652 adults 337 treating in six countries explored opinions relating from both perspectives, order correlate perceptions expectations diagnosis,...

10.1016/j.diabres.2014.05.005 article EN cc-by-nc-sa Diabetes Research and Clinical Practice 2014-05-27

Abstract Background To evaluate the association between diabetic foot disease (DFD) and incidence of fatal non-fatal events in individuals with type 2 diabetes (T2DM) from primary-care settings. Methods We built a cohort people first DFD episode during 2010–2015, followed up until 2018. These subjects were 1 to propensity score matched T2DM without DFD. The all-cause mortality, occurrence new DFD, amputations, cardiovascular diseases, or composite outcome, including mortality and/or...

10.1186/s12933-024-02303-1 article EN cc-by Cardiovascular Diabetology 2024-06-19

Among patients with type 2 diabetes, insulin intensification to achieve glycemic targets occurs less often than clinically indicated. Barriers are not well understood. We present patients' baseline characteristics from MOSAIc, a study investigating patient-, physician-, and healthcare environment-based factors affecting subsequent health outcomes. MOSAIc is longitudinal, observational following diabetes care in 18 countries: United Arab Emirates (UAE), Argentina, Brazil, Canada, China,...

10.1186/s12902-015-0044-z article EN cc-by BMC Endocrine Disorders 2015-09-09

Diabetic retinopathy (DR) is the leading cause of blindness in working age population developed countries. Albuminuria and estimated glomerular filtration rate (eGFR) have been considered biomarkers for DR. This study aimed to investigate prevalence DR its relationship with eGFR other risk factors type 2 diabetic patients (T2DM) Spain.A cross-sectional descriptive has performed 14,266 patients. Clinical records were reviewed. Demographic data, clinical diagnoses, variables, results from...

10.1016/j.jcte.2017.07.004 article EN cc-by-nc-nd Journal of Clinical & Translational Endocrinology 2017-07-29

Aim This study’s objective was to assess the risk of severe in-hospital complications patients admitted for COVID-19 and diabetes mellitus (DM). Design a cross-sectional study. Settings We used pseudonymised medical record data provided by six general hospitals from HM Hospitales group in Spain. Outcome measures Multiple logistic regression analyses were identify variables associated with mortality composite or invasive mechanical ventilation (IMV) overall population, stratified presence...

10.1136/bmjopen-2021-051237 article EN cc-by-nc-nd BMJ Open 2021-07-01
Pia Pajunen R. Landgraf F. Muylle Anne Neumann Jaana Lindström and 94 more Peter E. H. Schwarz Markku Peltonen Tania Acosta M. Adler Ala’a Alkerwi Noël C. Barengo R Barengo José Manuel Boavida Kate Charlesworth V. Christov B Claussen Xavier Cos E. Cosson S. Deceukelier Vesna Dimitrijević-Srećković Predrag Djordjević Philip Evans Anne Felton María Isabel Fischer Rafael Gabriel-Sánchez Aleksandra Gilis‐Januszewska Margalit Goldfracht J Gómez Colin Greaves Michael Hall Ulrich Handke Hans Hauner Jeffrey H. Herbst Norbert Hermanns L. Herrebrugh Claudia Huber U. Hühmer Jussi K. Huttunen Aleksandra Jotić Zdravko Kamenov S. Karadeniz Nikolaos Katsilambros Mykola Khalangot Katarzyna Kissimova‐Skarbek D Köhler Vincent J. Kopp Peter Kronsbein Bernhard Kulzer D. Kyne‐Grzebalski Katarina Lalić Nebojša Lalić R. Landgraf Y. Lee-Barkey Stavros Liatis Jaana Lindström Konstantinos Makrilakis C. McIntosh Martin McKee Ana Cristina Mesquita D. Misina F. Muylle Anne Neumann Anabela Paiva Pia Pajunen Bernhard Paulweber Markku Peltonen Luz Perrenoud A. Pfeiffer Auli Pölönen S. M. Puhl Falcão Raposo T. Reinehr A Rissanen Chris Robinson Michael Roden Ulrike Rothe Timo Saaristo Jamie L. Scholl Peter E. H. Schwarz K. Sheppard S. Spiers T. Stemper Bernd Stratmann J Szendroedi Z Szybiński Tsvetalina Tankova V. Telle-Hjellset G. Terry Daniel Tolks F. Toti Jaakko Tuomilehto A. Undeutsch Cristina Valadas Paul Valensi Džilda Veličkienė P. Vermunt Robert M. Weiss Johan Wens T. Yilmaz

The marked increase of type 2 diabetes necessitates active development and implementation efficient prevention programs. A European level action has been taken by launching the IMAGE project to unify improve various management concepts, which currently exist within EU. This report describes background methods used in quality indicators for primary It is targeted persons responsible at different levels health care systems.Development was conducted a group specialists representing professional...

10.1055/s-0029-1240976 article EN Hormone and Metabolic Research 2010-04-01

Abstract Background Diabetic foot and lower limb complications are an important cause of morbidity mortality among persons with diabetes mellitus. Very few studies have been carried out in the primary care settings. The main objective was to assess prognosis diabetic ulcer (DFU) patients from centers Catalonia, Spain, during a 12‐month follow‐up period. Methods We included participants type 2 new DFU between February 2018 July 2019. estimated incidence mortality, amputations, recurrence...

10.1186/s13047-023-00602-6 article EN cc-by Journal of Foot and Ankle Research 2023-01-01

To analyse the relation between face-to-face appointments and management of patients with type 2 diabetes mellitus (T2DM) visited in primary care practices (PCP).Retrospective study 287 (PCPs) attending>300,000 T2DM. We analysed results 9 diabetes-related indicators Healthcare quality standard, comprising foot retinopathy screening, blood pressure (BP) glycemic control; incidence calculated each indicator's percentage change 2020 respect to 2019.Indicators' were reduced compared 2019,...

10.1016/j.diabres.2021.109127 article EN cc-by-nc-nd Diabetes Research and Clinical Practice 2021-11-06

To determine the diagnostic performance of home blood pressure self-monitoring in white-coat hypertension using a 3-day reading program.One hundred and ninety nontreated patients recently diagnosed with mild-moderate hypertension, selected consecutively at four primary healthcare centers city Barcelona, were included. Each patient underwent morning night readings triplicate for three consecutive days, followed by 24-h ambulatory monitoring. The normality cut-off point value daytime...

10.1097/01.mbp.0000200479.19046.94 article EN Blood Pressure Monitoring 2006-03-13
Coming Soon ...